2020
DOI: 10.1016/j.cps.2019.12.002
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced Recovery After Surgery Pathways in Breast Reconstruction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
15
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(16 citation statements)
references
References 120 publications
0
15
0
1
Order By: Relevance
“…ERAS protocols have demonstrated ability to standardize postoperative stays and facilitate discharge. [12][13][14][15][16][17] Our study has exhibited the influence of patient expectation of discharge. We have shown that setting an expectation of a particular early discharge date can significantly affect the LOS.…”
Section: Discussionmentioning
confidence: 87%
See 3 more Smart Citations
“…ERAS protocols have demonstrated ability to standardize postoperative stays and facilitate discharge. [12][13][14][15][16][17] Our study has exhibited the influence of patient expectation of discharge. We have shown that setting an expectation of a particular early discharge date can significantly affect the LOS.…”
Section: Discussionmentioning
confidence: 87%
“…In this study, patients who were discharged earlier had a similar complication rates to those had a standard discharge and no patients had flap loss Several studies have analyzed ERAS protocols for microvascular breast reconstruction and have found decreased postoperative narcotic use and LOS. [12][13][14][15][16][17]29 Batdorf et al found that in their ERAS cohort of 49 individuals, they were able to reduce LOS from 5.5 to 3.9 days. 13 Astanehe et al similarly published a study on ERAS protocols for microvascular breast reconstruction, finding that the LOS for their ERAS cohort was 4.8 days, compared with their traditional cohort's LOS of 6.6 days.…”
Section: Discussionmentioning
confidence: 98%
See 2 more Smart Citations
“…El BPV nuevamente aparece como el gold standard para el manejo del dolor de estas cirugías. El último metanálisis a la fecha (29), demostró que este disminuía el dolor agudo de reposo y dinámico dentro de las primeras 72 hrs, incluso en estudios en donde no se usaron infusiones continuas; además, se observó una disminución en el consumo de opioides y en las náuseas y vómitos post operatorios, y una disminución de la estancia hospitalaria, convirtiéndose así, en una herramienta primordial en los protocolos ERAS para cirugía mayor de mama (30,31). Este bloqueo también se ha estudiado en cirugías menores de mama (tumorectomías, mastectomías parciales) evidenciando una disminución del consumo de opioides y menor dolor post operatorio en comparación con anestesia general; pero para los autores, este es un bloqueo que no se justifica para este tipo de cirugía al estar asociado a una serie de complicaciones que si bien son escasas, pueden ser catastróficas (32).…”
Section: Cirugía De Mamaunclassified